Skip to main content

Table 2 K-TEA Mean Baseline-to-Endpoint Scores

From: Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia

K-TEA Score, Mean (SE) Group Baseline Endpoint Change
Reading decoding standard ADHD 94.3 (9.1) 100.2 (13.5) 3.9 (2.1)
  ADHD+D 80.2 (7.6) 84.8 (10.6) 5.6 (1.8)a
Reading decoding age equiv, mo ADHD 137.7 (30.6) 158.1 (40.9) 17.8 (5.3)a
  ADHD+D 104.0 (12.2) 115.5 (22.2) 16.9 (5.7)a
Spelling standard ADHD 90.2 (15.6) 93.0 (16.9) 3.2 (1.1)a
  ADHD+D 80.1 (8.6) 82.1 (10.0) 1.5 (1.0)
Spelling age equiv, mo ADHD 132.6 (40.4) 140.6 (41.6) 9.7 (2.4)a
  ADHD+D 106.3 (18.9) 112.1 (25.7) 8.7 (2.2)a
Reading comprehension standard ADHD 98.9 (14.0) 104.0 (15.2) 5.6 (2.0)a
  ADHD+D 81.6 (10.8) 89.3 (13.8) 9.8 (1.7)a
Reading comprehension age equiv, mo ADHD 148.4 (41.0) 163.5 (43.8) 17.0 (5.7)a
  ADHD+D 106.5 (23.6) 124.8 (35.6) 26.0 (5.2)a
Reading composite standard ADHD 96.6 (11.6) 102.6 (14.9) 4.5 (1.8)a
  ADHD+D 80.3 (8.6) 86.4 (11.4) 8.1 (1.6)a
Reading composite age equiv, mo ADHD 144.3 (35.8) 161.9 (40.2) 17.2 (4.4)a
  ADHD+D 105.3 (16.6) 120.9 (26.5) 23.5 (4.3)a
  1. Last Observation Carried Forward LS Mean Change with no adjustments for number of tests conducted.
  2. a p-value ≤ .05 for within-group changes.
  3. Abbreviations: ADHD = attention-deficit/hyperactivity disorder group; ADHD+D = ADHD and dyslexia group; equiv = equivalent; mo = months; SE = standard error; K-TEA = Kaufman Test of Educational Achievement.